Modern biomedical engineering focuses more and more on the development of implant-associated local drug delivery systems for many different applications like stents for the treatment of coronary artery disease. A common method to deposit drugs on implants is their integration within a polymeric coating, which might however be contributor of adverse cardiac events. Moreover, modern implants pursue multimodal and time-controlled approaches, which require more sophisticated drug loading methods. In this context, a loading method based on surface depots that are selectively filled with drugs using a drop-on-demand printhead is investigated. As a first step small drug depots were produced by abrasive or additive laser-based methods on or into the surface of the implant. The range of the depot volumes varies between 1.4x10 5 and 1x10 7 ȝm³. These depots (cavity or tubes) can be filled with pure drugs, drug-polymer-mixtures and/or covered with biodegradable polymers using a piezoelectric drop-on-demand printhead. Therefore, the drugs are dissolved in methanol, ethanol or dimethyl sulfoxide (DMSO). The minimal droplet volume is about 100 pl. The quantity of drug per depot is specified by the number of droplets that are printed into the depots. The proof of principle of the loading method could be demonstrated on stainless steel samples as model implant surface. Drug depots were successfully filled with fluorescein disodium salt, dissolved in a mixture of 50 % DMSO and 50 % ethanol. Further drug depots were loaded with acetylsalicylic acid (ASS), dissolved in pure DMSO. Because of the low volume of a single droplet the depots could be filled very precisely.
Introduction
Two examples of drug eluting implants are e.g. drug eluting stents (DES) like the commercial CYPHER, TAXUS and ENDEAVOR [1] or intraocular lenses (IOL's) [2] . Especially drug eluting stents are in the focus of current investigations. The aforementioned DES are commercially available. The most widely used method to load drugs on these DES is to coat the bare metal stents with a mixture of drugs and biodegradable polymers. Thereby the drugs need to be incorporated in a high proportion of polymers. The presented method reduces the portion of polymers and increases the degree of freedom in geometrical design and drug eluting sequence.
Materials and Methods
The presented drug loading process is divided into two significant steps. First of all the depots are produced by abrasive or additive laser-based methods on or into the surface of the implant. The second main step is to fill the depots selectively with solved drugs by using a piezoelectric drop-on-demand printhead.
Drug depot preparation
Depots need a specific volume independent from geometry. Dependent from implant itself, implant material, drug concentration and drug composition two different types of depots were be loaded with the described loading method.
Drug depots placed into the surface
The first possibility to create drug depots is to drill them with a conventional nanosecond (ns) laser system into the surface. First samples are drilled with a Nd:YAG-laser (Trumpf VektorMark compact VMc4, Schramberg, Germany). The system is a frequency doubled Q-switch laser with a laser wavelength of Ȝ=532 nm and a minimal spot size of d §30 µm. Image 1 shows schematic drawings of such a depot.
Image 1 Schematic drawings of a laser drilled depot
Exemplary depots have a geometry like a truncated cone with an upper diameter of 100 µm and a lower diameter of circa 20 µm. The height is circa 50 µm. These dimensions of the assumed geometry result in a volume of circa V H =1. A second possibility to create drug depots is to use femtosecond (fs) laser pulses to generate cylindrical drug depots. Image 2 shows such a depot visualized by a light microscope (BX51, Olympus, Tokyo, Japan). These depots are characterized by sharper contours as by using ns-lasers.
Image 2 Drug depot drilled by fs-laser in stainless steel 316L
Depots drilled by Nd:YAG-laser were used to demonstrate the proof of principle of drug loading with fluorescein disodium salt visualized by a stereo microscope (Discovery.V20, Carl Zeiss AG, Oberkochen, Germany) and a fluorescence microscope (FLUOVIEW FV1000, Olympus, Tokyo, Japan). Depots drilled by fs-laser were loaded with acetylsalicylic acid (ASS).
Drug depots on top of implant surface
The second possibility to deposit drugs and polymers on surfaces is to integrate them into depots formed like microneedles. The production technique of micro laser melting is shown by Gieseke et al. in Ref. [4] and such a sample drug depot is shown in image 3.
Image 3 Drug depot produced by micro laser melting, material: stainless steel (1.4404)
2.2
Drug loading process
Drop-on-demand printheads
Two commercial drop-on-demand printheads were used in this study: on the one hand a PicPIP (GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH, Grosserkmannsdorf, Germany) (image 4a) and on the other hand a MD-K-130-562 (microdrop Technologies GmbH, Norderstedt, Germany) (image 4b). Both printheads are based on piezo-driven drop-on-demand technology. The integrated piezo actuator induces a shock-wave into the fluid contained in the head, which causes a droplet to be ejected from the nozzle. After this, the piezo actuator returns to its initial state and the dispenser is refilled with liquid from the reservoir. The printheads eject droplets with a volume between 100 pl and 200 pl with a repetition rate up to 1000 Hz.
Dissolution
A crucial factor during the loading process is the composition of solvents and drugs. In order to deposit the needed quantity of drugs into the depots, the dissolution has to be near the saturation limit. The reason is the small droplet size compared to the depot volume. Furthermore, the evaporation rate of the solvent has to guaranty, that no drugs are deposited at the dispenser tip and on the other hand that the solvent evaporates as fast as possible from the depot's surface to place the next droplet in.
To show the proof of principle fluorescein disodium salt (uranine, D&C yellow no. 8) was used. A mixture of 50 % dimethyl sulfoxide (DMSO) and 50 % ethanol as a solvent was used to deposit the uranine. The concentration of the dissolution was 5 mg uranine in 1 ml DMSO plus 1 ml EtOH. The surface of the substrate was heated up to 28° C with infrared light to accelerate the evaporation. Acetylsalicylic acid solved in pure DMSO was used as model drug. The dissolution consists of 5 mg ASS per 1 ml DMSO. 
Droplet volume
The volume of the generated depot depends on factors like implant material or implant geometry, e.g. stent strut thickness. Also the needed drug concentration plays an important role. Due to the upper diameter of the depots of circa 100 µm droplets with a diameter of circa 60 µm were chosen. The print head ejects regular round droplets. A spherical shape is assumed for the droplets, see image 6. Thus, the volume per droplet is about V D §1x10 5 µm³ ( §100 pl). The relation V H §V D shows, that one droplet per shot can be loaded into the depot. 5 mg per 1 ml (5x10 -3 ng/pl) ASS were solved in DMSO. So the mass per droplet M S =0.5 ng is deposited into the depot. To fill the maximum loadable mass (M D ) of ASS into the depot approx. 340 droplets with mass M S have to be deposited. The maximum loading frequency is 1 kHz. The evaporation rate of DMSO from implant's surface determines the loading process and is deemed to be the bottle neck. A heating of the substrate is helpful to accelerate the evaporation and thus the loading process.
Image 6 Spherical droplet from PicPip (GeSIM), diameter circa 60 µm
Results
To test the targeting precision of the loading process and to visualize the process depots with different profiles were filled with uranine. Image 7 shows on the left side microneedles taken by stereo microscope. On the right side of image 7 the same depots are recorded by confocal fluorescence microscope. The two figures on top show needles with an inner diameter of approx. 200 µm and the lower two figures with an inner diameter of approx. 100 µm. The needles were filled until the fluid builds a cap. Some uranine was deposited on the outer wall due to filling up to the top of the needles.
Image 7 Samples of micro-needles filled with uranine
Image 8 shows a hole drilled into the surface filled with the uranine dissolution. The upper diameter is approximately 100 µm. The deposited fluid quantity was exactly adjusted to the depot volume to avoid an overflow. To increase the inclusion of solid material into the depots a balance between evaporation rate and additional dissolution droplets has to be achieved. 
Conclusion
The study shows, that drop-on-demand printing is a possibility to load discrete drug depots on implant surfaces. On the one hand a separate loading of different zones on implant's surface is possible and on the other hand very small quantities of a drug can be applied very precisely. A time dependent drug eluting from each depot can be realized by loading different drugs and biodegradable polymers layer by layer into the depots. This technique facilitates new developments of drug eluting implants, nearby independent from the implant geometry and material.
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